 Biomerica Inc. NASDAQ: BMRA today announced it has signed a definitive agreement with the University of Texas Health Science Center at Houston UTH to join the clinical trial for Biomericas new InFoods diagnostic-guided therapy, designed to alleviate Irritable Bowel Syndrome IBS symptoms. The University of Texas Health Science Center at Houston is the fifth large medical center to be part of the InFoods clinical trial which includes: Mayo Clinic, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist and the University of Michigan as primary enrollment centers. 